about
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. ...
Read More
1.75
-0.05
(-2.78%)
51,043.6
XNAS Volume
High vol. this week
XNAS 17 Jul, 2026 10:13 AM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
MetaVia Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..